Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers

Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and... BRIEF REPORT Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers Shinya Neri, MD,* Yutaka Takahashi, MD, PhD,* Takuya Terashi, MD,* Hiroshi Hamakawa, MD,* Keisuke Tomii, MD, PhD,† Nobuyuki Katakami, MD, PhD,‡ and Masaki Kokubo, MD, PhD§ 1– 4 mors. Especially in stage I NSCLC, the local control Introduction: Stereotactic body radiotherapy (SBRT) has been 1–3 rate is documented to exceed 85%. Thus, SBRT could proposed as an alternative to surgery for the treatment of lung serve as a treatment alternative in patients who are fit to cancer. The treatment of local recurrence that occurs after SBRT has undergo anatomic resection. not been reported. We present surgical outcomes for local recurrence Several patterns of disease recurrence after SBRT have following SBRT for primary and metastatic lung cancers. 1,5 been reported. These include local recurrence, regional lymph Methods: Seven of the patients who received SBRT between 2002 and metastasis, and distant metastasis. Resection or repeat SBRT as 2008 underwent salvage surgery for local recurrence. These seven salvage therapy for such local recurrences has been reported, patients (two with stage I non-small cell lung cancer and five with but few published reports have described the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers

Kokubo, Masaki
Journal of Thoracic Oncology , Volume 5 (12) – Dec 1, 2010
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/surgical-treatment-of-local-recurrence-after-stereotactic-body-r45j2Ojwfr

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181f8a785
pmid
21102262
Publisher site
See Article on Publisher Site

Abstract

BRIEF REPORT Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers Shinya Neri, MD,* Yutaka Takahashi, MD, PhD,* Takuya Terashi, MD,* Hiroshi Hamakawa, MD,* Keisuke Tomii, MD, PhD,† Nobuyuki Katakami, MD, PhD,‡ and Masaki Kokubo, MD, PhD§ 1– 4 mors. Especially in stage I NSCLC, the local control Introduction: Stereotactic body radiotherapy (SBRT) has been 1–3 rate is documented to exceed 85%. Thus, SBRT could proposed as an alternative to surgery for the treatment of lung serve as a treatment alternative in patients who are fit to cancer. The treatment of local recurrence that occurs after SBRT has undergo anatomic resection. not been reported. We present surgical outcomes for local recurrence Several patterns of disease recurrence after SBRT have following SBRT for primary and metastatic lung cancers. 1,5 been reported. These include local recurrence, regional lymph Methods: Seven of the patients who received SBRT between 2002 and metastasis, and distant metastasis. Resection or repeat SBRT as 2008 underwent salvage surgery for local recurrence. These seven salvage therapy for such local recurrences has been reported, patients (two with stage I non-small cell lung cancer and five with but few published reports have described the

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Dec 1, 2010

References

  • Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study
    Onishi
  • Stereotactic body radiation therapy for inoperable early stage lung cancer
    Timmerman
  • Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer
    Lagerwaard
  • Stereotactic radiotherapy for pulmonary oligometastases: a systematic review
    Siva
  • Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy
    Milano
  • Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study
    Onishi
  • Defining a uniform biologically effective dose for organs with parallel architecture
    Yaes
  • Effect of preoperative irradiation on wound healing after bronchial anastomosis in mongrel dogs
    Inui
  • Reconstructive airway operation after irradiation
    Muehrcke
  • Clinical and histopathologic features of recurrent vestibular schwannoma (acoustic neuroma) after stereotactic radiosurgery
    Lee
  • Results of surgery following stereotactic irradiation for acoustic neuromas
    Slattery
  • Fibroblasts in cancer
    Kalluri
  • Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
    Shimoda
  • Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT
    Takeda
  • FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
    Hoopes